Evidence map›Paper›PMID 26713879›Full record

ArticlePloS one2015

Roles of Asp179 and Glu270 in ADP-Ribosylation of Actin by Clostridium perfringens Iota Toxin.

Alexander Belyy, Irina Tabakova, Alexander E Lang, Thomas Jank, Yury Belyi, Klaus Aktories

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Prevalence of ExoY Activity inFrontiers in microbiology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Alexander BelyyGamaleya Research Institute, Moscow, Russia.
Irina TabakovaGamaleya Research Institute, Moscow, Russia.
Alexander E LangInstitute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany.
Thomas JankInstitute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany.
Yury BelyiGamaleya Research Institute, Moscow, Russia.
Klaus AktoriesInstitute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany.
Gamalei Institute of Epidemiology and Microbiology · RUUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridium perfringens iota toxin is a binary toxin composed of the enzymatically active component Ia and receptor binding component Ib. Ia is an ADP-ribosyltransferase, which modifies Arg177 of actin. The previously determined crystal structure of the actin-Ia complex suggested involvement of Asp179 of actin in the ADP-ribosylation reaction. To gain more insights into the structural requirements of actin to serve as a substrate for toxin-catalyzed ADP-ribosylation, we engineered Saccharomyces cerevisiae strains, in which wild type actin was replaced by actin variants with substitutions in residues located on the Ia-actin interface. Expression of the actin mutant Arg177Lys resulted in complete resistance towards Ia. Actin mutation of Asp179 did not change Ia-induced ADP-ribosylation and growth inhibition of S. cerevisiae. By contrast, substitution of Glu270 of actin inhibited the toxic action of Ia and the ADP-ribosylation of actin. In vitro transcribed/translated human β-actin confirmed the crucial role of Glu270 in ADP-ribosylation of actin by Ia.

Indexed as

ActinsAdenosine Diphosphate RiboseADP Ribose TransferasesAmino Acid SequenceAmino Acid SubstitutionAspartic AcidBacterial ToxinsGlutamic AcidHumansModels, MolecularMolecular Sequence DataProtein ConformationSaccharomyces cerevisiaeActinsAdenosine Diphosphate RiboseADP Ribose TransferasesAspartic AcidBacterial ToxinsGlutamic Acidiota toxin, Clostridium perfringens

Identifiers

PMID26713879
PMCPMC4699905
OpenAlexW2208250680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.